Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
146,485
-
Share change
-
-1,372,304
-
Total reported value
-
$352,000
-
Price per share
-
$2.39
-
Number of holders
-
7
-
Value change
-
-$5,020,392
-
Number of buys
-
5
-
Number of sells
-
10
Institutional Holders of Immix Biopharma, Inc. - Common Stock (IMMX) as of Q1 2022
As of 31 Mar 2022,
Immix Biopharma, Inc. - Common Stock (IMMX) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
146,485 shares.
The largest 7 holders included
RENAISSANCE TECHNOLOGIES LLC, Virtu Financial LLC, CITADEL ADVISORS LLC, InterOcean Capital Group, LLC, XTX Topco Ltd, BlackRock Inc., and ADVISOR GROUP HOLDINGS, INC..
This page lists
7
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.